Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 12:20 AM
Ignite Modification Date:
2025-12-25 @ 12:20 AM
NCT ID:
NCT02149758
Brief Summary:
The hypothesis is that Etoricoxib act as an adjuvant to SRP in alleviating periodontal inflammation by:
1. improving clinical periodontal parameters and,
2. improving the salivary SOD levels.
Study:
NCT02149758
Study Brief:
Protocol Section:
NCT02149758